Celltrion Inc – Strategy, SWOT and Corporate Finance Report

Celltrion Inc – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360Ëš view of the company

Key Highlights

Celltrion Inc (Celltrion) is a biopharmaceutical company that focuses on research, development and manufacture of biosimilars and novel biopharmaceuticals. The company offers monoclonal antibodies for the treatment of rheumatoid arthritis, ankylosing spondylitis, ulcerative colitis, adult Crohn’s disease, psoriatic arthritis and psoriasis. Its pipeline portfolio spans monoclonal antibody biosmilars for the treatment of rheumatoid arthritis; colorectal cancer; and respiratory disease; and antibody biologics for and vaccines for infectious diseases such as hepatitis B, influenza, rabies, breast cancer and seasonal influenza. Celltrion develops drugs by utilizing its bioengineering and mammalian cell-culture technology. The company also carries out contract manufacturing of biosimilars. It has operational presence in Korea, Russia, the UK, and the US. Celltrion is headquartered in Incheon city, South Korea.

Scope

Detailed information on Celltrion Inc required for business and competitor intelligence needs

A study of the major internal and external factors affecting Celltrion Inc in the form of a SWOT analysis

An in-depth view of the business model of Celltrion Inc including a breakdown and examination of key business segments

News about Celltrion Inc, such as business expansion, restructuring, and contract wins

Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

Gain understanding of Celltrion Inc and the factors that influence its strategies.

Track strategic initiatives of the company and latest corporate news and actions.

Assess Celltrion Inc as a prospective partner, vendor or supplier.

Support sales activities by understanding your customers' businesses better.

Stay up to date on Celltrion Incs business structure, strategy and prospects.

Note: Some sections may be missing if data is unavailable for the company.

Companies mentioned

ViroMed Co Ltd

Peptron Inc

JW Pharmaceutical Corp

Genexine Inc

ChoongAng Vaccine Laboratory

Biosolution Co Ltd

Alvogen Korea Co Ltd

Advanced Protein Technologies Corp

Table of Contents

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1 - About the Company

Celltrion Inc - Key Facts

Celltrion Inc - Key Employees

Celltrion Inc - Key Employee Biographies

Celltrion Inc - Major Products and Services

Celltrion Inc - History

Celltrion Inc - Company Statement

Celltrion Inc - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2 Company Analysis

Company Overview

Celltrion Inc - Business Description

Business Segment: Biopharmaceuticals

Overview

Performance

Business Segment: Chemical Medicines

Overview

Performance

Business Segment: Other

Overview

Performance

R&D Overview

Celltrion Inc - SWOT Analysis

SWOT Analysis - Overview

Celltrion Inc - Strengths

Celltrion Inc - Weaknesses

Celltrion Inc - Opportunities

Celltrion Inc - Threats

Celltrion Inc - Key Competitors

Section 3 Company Financial Ratios

Financial Ratios - Capital Market Ratios

Financial Ratios - Annual Ratios

Performance Chart

Financial Performance

Financial Ratios - Interim Ratios

Financial Ratios - Ratio Charts

Section 4 Company’s Lifesciences Financial Deals and Alliances

Celltrion Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Celltrion Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Celltrion Inc, Recent Deals Summary

Section 5 Company’s Recent Developments

Oct 23, 2018: Celltrion Healthcare organizes forum with patient interest groups to provide information on the use of biosimilar drugs in oncology

Oct 04, 2018: Celltrion to Complete Expansion in Incheon, South Korea Facility

Sep 25, 2018: FDA Issues Form 483 to Celltrion Inc

Sep 18, 2018: Celltrion receives EIR from the FDA

Jun 26, 2018: Celltrion to Launch Bio CDMO in Incheon, South Korea

Jun 05, 2018: Celltrion Launches Bio CDMO Business for the Development of New Drugs

May 16, 2018: FDA Issues Complete Response Letters to Celltrion for Two Biosimlars

Section 6 Appendix

Methodology

Ratio Definitions

About GlobalData

Contact Us

Disclaimer

List of Tables

List of Tables

Celltrion Inc, Key Facts

Celltrion Inc, Key Employees

Celltrion Inc, Key Employee Biographies

Celltrion Inc, Major Products and Services

Celltrion Inc, History

Celltrion Inc, Subsidiaries

Celltrion Inc, Key Competitors

Celltrion Inc, Ratios based on current share price

Celltrion Inc, Annual Ratios

Celltrion Inc, Annual Ratios (Cont…1)

Celltrion Inc, Annual Ratios (Cont…2)

Celltrion Inc, Interim Ratios

Celltrion Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Celltrion Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Celltrion Inc, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

List of Figures

List of Figures

Celltrion Inc, Performance Chart (2014 – 2018)

Celltrion Inc, Ratio Charts

Celltrion Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Celltrion Inc, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019

    Pricing

Discounts available for multiple report purchases.

reportstore@marketline.com
+44 (0) 161 359 5817

Saved reports